1273. Activity of Ceftolozane/Tazobactam and Comparators Against Enterobacterales and P. aeruginosa Isolates from Pediatric Patients—SMART United States 2017-2019

BACKGROUND: Ceftolozane/tazobactam (C/T) is an antipseudomonal cephalosporin combined with a β-lactamase inhibitor approved by FDA and EMA for complicated urinary tract (cUTI) and complicated intraabdominal infections (cIAI), as well as hospital-acquired/ventilator-associated bacterial pneumonia (HA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lob, Sibylle, Hackel, Meredith, Andrew DeRyke, C, Harris, Kelly, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643961/
http://dx.doi.org/10.1093/ofid/ofab466.1465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643961/
http://dx.doi.org/10.1093/ofid/ofab466.1465

Ejemplares similares